AAAAAA
Results: 26-50/113
Authors:
TIRELLI U
ERRANTE D
SANTAROSSA S
SPINA M
GISSELBRECHT C
MAROLLEAU JP
KERNEIS Y
RIDOLFO A
BOTTURA P
PAN A
DELLEFOGLIE P
ROSSI G
TAVIO M
VACCHER E
Citation: U. Tirelli et al., EPIRUBICIN, BLEOMYCIN, VINBLASTINE AND PREDNISONE (EBVP) CHEMOTHERAPY(CT) IN COMBINATION WITH ANTIRETROVIRAL THERAPY AND PRIMARY USE OF G-CSF FOR PATIENTS (PTS) WITH HODGKINS-DISEASE AND HIV-INFECTION (HD-HIV), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 63-63
Authors:
GISSELBRECHT C
SPINA M
GABARRE J
RIZZARDINI G
SCHLAIFER D
NIGRA E
BOUABDALLAH R
SCHRAPPE M
RAPOPORT B
CARBONE C
RAPHAEL M
TIRELLI U
Citation: C. Gisselbrecht et al., THERAPY OF HIV-RELATED NON-HODGKINS-LYMPHOMA - AN EUROPEAN MULTICENTRIC RANDOMIZED STUDY IN PATIENTS STRATIFIED ACCORDING TO THEIR PROGNOSTIC FACTORS - PRELIMINARY-RESULTS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 149-149
Authors:
GISSELBRECHT C
HAIOUN C
LEPAGE E
BASTION Y
TILLY H
BOSLY A
DUPRIEZ B
MARIT G
HERBRECHT R
DECONINCK E
MAROLLEAU JP
YVER A
DABOUZHARROUCHE F
COIFFIER B
REYES F
Citation: C. Gisselbrecht et al., PLACEBO-CONTROLLED PHASE-III STUDY OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA - FACTORS INFLUENCING CHEMOTHERAPY ADMINISTRATION, Leukemia & lymphoma, 25(3-4), 1997, pp. 289-300
Authors:
WENDUM D
SEBBAN C
GAULARD P
COIFFIER B
TILLY H
CAZALS D
BOEHN A
CASASNOVAS RO
BOUABDALLAH R
JAUBERT J
FERRANT A
DIEBOLD J
DEMASCAREL A
GISSELBRECHT C
Citation: D. Wendum et al., FOLLICULAR LARGE-CELL LYMPHOMA TREATED WITH INTENSIVE CHEMOTHERAPY - AN ANALYSIS OF 89 CASES INCLUDED IN THE LNH87 TRIAL AND COMPARISON WITH THE OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA, Journal of clinical oncology, 15(4), 1997, pp. 1654-1663
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
BASTION Y
COIFFIER B
BRICE P
BOSLY A
DUPRIEZ B
NOUVEL C
TILLY H
LEDERLIN P
BIRON P
BRIERE J
GAULARD P
REYES F
Citation: C. Haioun et al., BENEFIT OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION OVER SEQUENTIAL CHEMOTHERAPY IN POOR-RISK AGGRESSIVE NON-HODGKINS-LYMPHOMA - UPDATED RESULTS OF THE PROSPECTIVE-STUDY LNH87-2, Journal of clinical oncology, 15(3), 1997, pp. 1131-1137
Authors:
CHEZE S
GAULARD P
COIFFIER B
BOULAT O
BAGLIN AC
BAUMELOU E
RAYMONDGELLE MC
GISSELBRECHT C
DIEBOLD J
LEPORRIER M
Citation: S. Cheze et al., NASAL T-NATURAL-KILLER (NK) CELL LYMPHOMA - CLINICOPATHOLOGICAL STUDYOF 10 CASES FROM THE GELA LNH-87 PROTOCOL, Blood, 90(10), 1997, pp. 3881-3881
Authors:
HAIOUN C
LEPAGE E
SALLES G
MOREL P
GABARRE J
LEDERLIN P
TILLY H
BOSLY A
GAULARD P
COIFFIER B
GISSELBRECHT C
REYES F
Citation: C. Haioun et al., BONE-MARROW INVOLVEMENT AND LOW SERUM-ALBUMIN LEVEL ARE USEFUL TO BETTER PREDICT SURVIVAL OF POOR-RISK PATIENTS WITH AGGRESSIVE LYMPHOMA ASDEFINED BY THE AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX (AA-IPI), Blood, 90(10), 1997, pp. 3899-3899
Authors:
SIMON D
GISSELBRECHT C
SEBBAN C
REYES F
BOSLY A
GABARRE J
MOREL P
BOULAT O
LEPAGE E
Citation: D. Simon et al., IDENTIFICATION OF INFECTION PROGNOSTIC FACTORS IN AGGRESSIVE NON-HODGKIN LYMPHOMAS TREATED WITH MYELOSUPPRESSIVE CYCLES OF CHEMOTHERAPY, Blood, 90(10), 1997, pp. 3956-3956
Authors:
REMAN O
BROUSSE N
SOLALCELIGNY P
MORELLO R
LEDERLIN P
CHRISTIAN D
MOREL P
BLANC M
PICO J
BOULAT O
CONROY T
GISSELBRECHT C
HAIOUN C
MARTIN D
TURLURE P
SIMON M
DABOUT D
LEPORRIER M
Citation: O. Reman et al., 2-CHLORODEOXYADENOSINE (2CDA) IN RELAPSING OR REFRACTORY FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 1531-1531
Authors:
HAIOUN C
GISSELBRECHT C
QUESNEL B
MOREL P
REYES F
Citation: C. Haioun et al., DOUBLE AUTOTRANSPLANT (DAT) AS FIRST LINE CONSOLIDATIVE TREATMENT IN POOR-RISK AGGRESSIVE LYMPHOMA - A PILOT-STUDY OF 31 PATIENTS, Blood, 90(10), 1997, pp. 1698-1698
Authors:
MOREL P
MUNCK JN
COIFFIER B
GISSELBRECHT C
LEDERLIN P
LAVAUD A
BOSLY A
TILLY H
QUESNEL B
THYSS A
SCHLAIFER D
BRIERE J
REYES F
Citation: P. Morel et al., ECVB - A NEW HIGH-DOSE CHOP REGIMEN FOLLOWED BY AN INTENSIVE CONSOLIDATION IN PATIENTS (PTS) AGED LESS-THAN-OR-EQUAL-TO-60 YEARS WITH AGGRESSIVE LYMPHOMA (NHL) PRESENTING WITH ONLY ONE ADVERSE PROGNOSTIC FACTOR OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) - AN INTERIM ANALYSIS OFTHE LNH93-2 PROTOCOL ON 433 PTS, Blood, 90(10), 1997, pp. 2610-2610
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Blood, 90(10), 1997, pp. 2639-2639
Authors:
REYES F
LEPAGE E
MOREL P
LEDERLIN P
COIFFIER B
TILLY H
BOSLY A
GABARRE J
BRIERE J
FILLET G
MOLINA T
GISSELBRECHT C
Citation: F. Reyes et al., FAILURE OF FIRST-LINE INDUCTIVE HIGH-DOSE CHEMOTHERAPY (HDC) IN POOR-RISK PATIENTS (PTS) WITH AGGRESSIVE LYMPHOMA - UPDATED RESULTS OF THE RANDOMIZED LNH93-3 STUDY, Blood, 90(10), 1997, pp. 2640-2640
Authors:
GISSELBRECHT C
Citation: C. Gisselbrecht, AUTOLOGOUS STEM-CELL TRANSPLANTATION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA, HEM CELL TH, 38(4), 1996, pp. 297-304
Authors:
BRICE P
MAROLLEAU JP
PAUTIER P
MAKKE J
CAZALS D
DOMBRET H
DAGAY MF
BENBUNAN M
GISSELBRECHT C
Citation: P. Brice et al., HEMATOLOGIC RECOVERY AND SURVIVAL OF LYMPHOMA PATIENTS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - COMPARISON OF BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR CELLS, Leukemia & lymphoma, 22(5-6), 1996, pp. 449-456
Authors:
GUERCI A
LEDERLIN P
REYES F
BORDESSOULE D
SEBBAN C
TILLY H
KERNEIS Y
BIRON P
GISSELBRECHT C
HERBRECHT R
COIFFIER B
Citation: A. Guerci et al., EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ADMINISTRATION IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA TREATED WITH A PIRARUBICIN-COMBINATION CHEMOTHERAPY REGIMEN, Annals of oncology, 7(9), 1996, pp. 966-969
Authors:
SWEETENHAM JW
PEARCE R
TAGHIPOUR G
BLAISE D
GISSELBRECHT C
GOLDSTONE AH
Citation: Jw. Sweetenham et al., ADULT BURKITT AND BURKITT-LIKE NON-HODGKINS-LYMPHOMA - OUTCOME FOR PATIENTS TREATED WITH HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN FIRST REMISSION OR AT RELAPSE - RESULTS FROM THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION, Journal of clinical oncology, 14(9), 1996, pp. 2465-2472
Authors:
BLAISE D
ATTAL M
REIFFERS J
MOLINA L
BELLANGER C
PICO JL
NEDELEC G
VERNANT JP
TROUSSARD X
LEGROS M
GISSELBRECHT C
ROSSI JF
BRANDELY M
HERCEND T
MARANINCHI D
Citation: D. Blaise et al., A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1, Experimental hematology, 24(9), 1996, pp. 368-368
Authors:
GISSELBRECHT C
EXTRA JM
LOTZ JP
DEVAUX Y
JANVIER M
PENY AM
GUILLEVIN L
BREMOND D
DELAIN M
HERBRECHT R
LEPAGE E
MARANINCHI D
Citation: C. Gisselbrecht et al., CYCLOPHOSPHAMIDE MITOXANTRONE/MELPHALAN (CMA) REGIMEN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN METASTATIC BREAST-CANCER/, Bone marrow transplantation, 18(5), 1996, pp. 857-863
Authors:
MAROLLEAU JP
BRICE P
DALCORTIVO L
FERMAND JP
ROBERT I
MICLEA JM
CHAIBI P
GISSELBRECHT C
MILLS B
KUNKEL L
OLDHAM F
BENBUNAN M
Citation: Jp. Marolleau et al., CD34-300) FOR PATIENTS WITH MALIGNANCIES( SELECTION BY IMMUNOMAGNETICSELECTION (ISOLEX(R)), Blood, 88(10), 1996, pp. 427-427
Authors:
GISSELBRECHT C
LEPAGE E
MOREL P
LEDERLIN P
COIFFIER B
TILLY H
BOSLY A
GABARRE J
BRIERE J
FILLET G
MOLINA T
REVES F
Citation: C. Gisselbrecht et al., INTENSIFIED INDUCTION-PHASE INCLUDING AUTOLOGOUS PERIPHERAL STEM-CELLTRANSPLANTATION DOES NOT IMPROVE RESPONSE RATE AND SURVIVAL IN LYMPHOMA WITH AT LEAST 2 ADVERSE PROGNOSTIC FACTORS WHEN COMPARED TO ACVB REGIMEN, Blood, 88(10), 1996, pp. 470-470
Authors:
ANDRE M
HENRYAMAR M
PICO JL
BASTION Y
BLAISE D
KUENTZ M
COLOMBAT P
CAHN JY
ATTAL M
FLEURY J
MILPIED N
BIRON P
NEDELLEC G
JOUET JP
TILLY R
FERME C
GISSELBRECHT C
Citation: M. Andre et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY, Blood, 88(10), 1996, pp. 479-479
Authors:
GISSELBRECHT C
GAULARD P
LEPAGE E
COIFFIER B
BRIERE FJ
HAIOUN C
CAZALS D
BOSLY A
XERRI L
TILLY H
BERGER F
BOUHABDALLAH R
DIEBOLD J
Citation: C. Gisselbrecht et al., PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 1159-1159
Authors:
DETOURMIGNIES L
COPIN MC
MOREL P
VANRUMBEKE M
PREUDHOMME C
WATTEL E
GAULARD P
GISSELBRECHT C
GOSSELIN B
FENAUX P
Citation: L. Detourmignies et al., P53 OVEREXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMA (DLCL) AND ITS PROGNOSTIC VALUE BY MULTIPARAMETER ANALYSIS, Blood, 88(10), 1996, pp. 1521-1521
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
TERTIAN G
THYSS A
REMAN O
SEBBAN C
PIGNON B
GISSELBRECHT C
COIFFIER B
COLE B
SUGANO D
TENDLER C
Citation: P. Solalceligny et al., A DOXORUBICIN CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B (IFN-ALPHA 2B) IN ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL, TOXICITY AND QUALITY-OF-LIFE OF THE GELF86 TRIAL, Blood, 88(10), 1996, pp. 1800-1800